Literature DB >> 15019009

Distribution-based criteria for change in health-related quality of life in Parkinson's disease.

Ray Fitzpatrick1, Josephine M Norquist, Crispin Jenkinson.   

Abstract

BACKGROUND AND
OBJECTIVE: To be useful, results from health-related quality of life (HRQoL) measures must be interpretable. The objective of this article is to examine statistical (distributional) approaches to interpretability. The standard error of measurement (SEM) and the standard error of the difference (S(diff)) are used in data on individuals with Parkinson's disease to calculate the minimum change scores required to be statistically meaningful for each dimension of an instrument to assess HRQoL in Parkinson's disease, the PDQ-39.
METHODS: Data was collected from both a community and a clinic study; in both studies the PDQ-39 was administered at baseline and follow-up.
RESULTS: The patterns of SEMs and S(diff)s were similar both across time periods and between samples, for all dimensions except Social Support.
CONCLUSIONS: The results suggest that, for example, six points change on a 0-100 transformed scoring of the Mobility dimension may be considered on distributional grounds a minimum meaningful change. The demonstrated consistency across occasions and types of sample of SEMs and S(diff) for the majority of the dimensions of the PDQ-39, is evidence of the theoretically claimed advantage of this measure of sample independence, and supports use of this distributional approach to minimum meaningful change.

Entities:  

Mesh:

Year:  2004        PMID: 15019009     DOI: 10.1016/j.jclinepi.2003.07.003

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  15 in total

1.  Health-related quality of life as an outcome variable in Parkinson's disease.

Authors:  Pablo Martinez-Martin; Mónica M Kurtis
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

2.  The quality of life of parents of children with atopic dermatitis: interpretation of PIQoL-AD scores.

Authors:  D M Meads; S P McKenna; K Kahler
Journal:  Qual Life Res       Date:  2005-12       Impact factor: 4.147

3.  Clinically meaningful improvement on the Self-Esteem And Relationship questionnaire in men with erectile dysfunction.

Authors:  Joseph C Cappelleri; Stanley E Althof; Michael P O'Leary; Sidney Glina; Rosie King; Vera J Stecher; Martin Carlsson; Richard L Siegel
Journal:  Qual Life Res       Date:  2007-07-07       Impact factor: 4.147

4.  Regular Exercise, Quality of Life, and Mobility in Parkinson's Disease: A Longitudinal Analysis of National Parkinson Foundation Quality Improvement Initiative Data.

Authors:  Miriam R Rafferty; Peter N Schmidt; Sheng T Luo; Kan Li; Connie Marras; Thomas L Davis; Mark Guttman; Fernando Cubillos; Tanya Simuni
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

5.  Self-management rehabilitation and health-related quality of life in Parkinson's disease: a randomized controlled trial.

Authors:  Linda Tickle-Degnen; Terry Ellis; Marie H Saint-Hilaire; Cathi A Thomas; Robert C Wagenaar
Journal:  Mov Disord       Date:  2010-01-30       Impact factor: 10.338

6.  Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS).

Authors:  James Twiss; Lynda C Doward; Stephen P McKenna; Benjamin Eckert
Journal:  Health Qual Life Outcomes       Date:  2010-10-11       Impact factor: 3.186

7.  Treatment of idiopathic Parkinson's disease with traditional chinese herbal medicine: a randomized placebo-controlled pilot clinical study.

Authors:  Wan Fung Kum; Siva Sundara Kumar Durairajan; Zhao Xiang Bian; Sui Cheung Man; Yuen Chi Lam; Li Xia Xie; Jia Hong Lu; Yan Wang; Xian Zhang Huang; Min Li
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-18       Impact factor: 2.629

Review 8.  Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review.

Authors:  Jenni Hislop; Temitope E Adewuyi; Luke D Vale; Kirsten Harrild; Cynthia Fraser; Tara Gurung; Douglas G Altman; Andrew H Briggs; Peter Fayers; Craig R Ramsay; John D Norrie; Ian M Harvey; Brian Buckley; Jonathan A Cook
Journal:  PLoS Med       Date:  2014-05-13       Impact factor: 11.069

9.  Psychometric validation of a multi-dimensional capability instrument for outcome measurement in mental health research (OxCAP-MH).

Authors:  Francis Vergunst; Crispin Jenkinson; Tom Burns; Paul Anand; Alastair Gray; Jorun Rugkåsa; Judit Simon
Journal:  Health Qual Life Outcomes       Date:  2017-12-28       Impact factor: 3.186

10.  Effect on Gait Speed, Balance, Motor Symptom Rating, and Quality of Life in Those with Stage I Parkinson's Disease Utilizing LSVT BIG®.

Authors:  Beth Millage; Erin Vesey; Marsha Finkelstein; Mattie Anheluk
Journal:  Rehabil Res Pract       Date:  2017-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.